Search Result "RAF-1"


Synthesis and Biological Evaluations of 3-Benzothiazol-2-yl Coumarin Derivatives as MEK1 Inhibitors

Journal: Letters in Drug Design & Discovery
Volume: 10 Issue: 8 Year: 2013 Page: 727-732
Author(s): Chao Wang,Fengrong Xu,Yan Niu,Yun Wu,Jing Sun,Yihong Peng,Lei Liang,Ping Xu

Signal Transduction in Human Cutaneous Melanoma and Target Drugs

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 8 Year: 2013 Page: 843-866
Author(s): Anatoly B. Uzdensky,Svetlana V. Demyanenko,Mikhail Y. Bibov

Selumetinib in Advanced Non Small Cell Lung Cancer (NSCLC) Harbouring KRAS Mutation: Endless Clinical Challenge to KRAS-mutant NSCLC.

Journal: Reviews on Recent Clinical Trials
Volume: 8 Issue: 2 Year: 2013 Page: 93-100
Author(s): Paolo Maione,Assunta Sgambato,Antonio Rossi,Paola Claudia Sacco,Maria Anna Bareschino,Clorinda Schettino,Francesca Casaluce,Fortunato Ciardiello,Cesare Gridelli

Modulation of Sensitivity to Antitumor Agents by Targeting the MAPK Survival Pathway

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 883-894
Author(s): Giacomo Cossa,Laura Gatti,Giuliana Cassinelli,Cinzia Lanzi,Nadia Zaffaroni,Paola Perego

Studies of NVP-BEZ235 in Melanoma

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 2 Year: 2013 Page: 165-174
Author(s): Joshua A. Sznol, Lucia B. Jilaveanu, Harriet M. Kluger

Novel Anticancer Agents and Targets: Recent Advances and Future Perspectives

Journal: Mini-Reviews in Medicinal Chemistry
Volume: 13 Issue: 9 Year: 2013 Page: 1239-1255
Author(s): Kuldipsinh P. Barot,Stoyanka Nikolova,Illiyan Ivanov,Manjunath D. Ghate

Molecular Mechanisms and Modulation of Key Pathways Underlying the Synergistic Interaction of Sorafenib with Erlotinib in Non-Small-Cell-Lung Cancer (NSCLC) Cells

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 5 Year: 2013 Page: 927-939
Author(s): E. Giovannetti,M. Labots,H. Dekker,E. Galvani,J.S.W. Lind,R. Sciarrillo,R. Honeywell,E.F. Smit,H.M. Verheul,G.J. Peters

Unmet Needs in Ovarian Cancer: Dividing Histologic Subtypes to Exploit Novel Targets and Pathways

Journal: Current Cancer Drug Targets
Volume: 13 Issue: 6 Year: 2013 Page: 698-707
Author(s): Vijaya Galic,Robert L. Coleman,Thomas J. Herzog

Multidisciplinary Approach to Patient with Malignant Melanoma

Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 13 Issue: 6 Year: 2013 Page: 887-900
Author(s): Giuseppina Della Vittoria Scarpati,Celeste Fusciello,Francesco Sabbatino,Soldano Ferrone,Francesco Caponigro,Francesco Perri,Chiara Carlomagno,Stefano Pepe

The Therapeutic Target Hsp90 and Cancer Hallmarks

Journal: Current Pharmaceutical Design
Volume: 19 Issue: 3 Year: 2013 Page: 347-365
Author(s): Yoshihiko Miyata,Hitoshi Nakamoto,Len Neckers

Previous   Next

Go To   Results 1 - 1 of 166

Filter Result

Volume Year
Content Type
Ads
© 2024 Bentham Science Publishers | Privacy Policy